709 related articles for article (PubMed ID: 25109834)
1. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway.
Xu S; Zhou W; Ge J; Zhang Z
Mol Med Rep; 2018 Mar; 17(3):4702-4712. PubMed ID: 29328471
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.
Zhang M; Zhang H; Cheng S; Zhang D; Xu Y; Bai X; Xia S; Zhang L; Ma J; Du M; Wang Y; Wang J; Chen M; Leng J
Tumour Biol; 2014 Jul; 35(7):7135-45. PubMed ID: 24760275
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
[TBL] [Abstract][Full Text] [Related]
5. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression.
Ma J; Chen M; Xia SK; Shu W; Guo Y; Wang YH; Xu Y; Bai XM; Zhang L; Zhang H; Zhang M; Wang YP; Leng J
Int J Oncol; 2013 Mar; 42(3):1093-104. PubMed ID: 23338277
[TBL] [Abstract][Full Text] [Related]
7. PGE
Gonzalez AA; Salinas-Parra N; Leach D; Navar LG; Prieto MC
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1038-F1049. PubMed ID: 28701311
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression.
Zhang H; Cheng S; Zhang M; Ma X; Zhang L; Wang Y; Rong R; Ma J; Xia S; Du M; Shi F; Wang J; Yang Q; Bai X; Leng J
Int J Oncol; 2014 Mar; 44(3):769-80. PubMed ID: 24378923
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin inhibits lipopolysaccharide-induced cell migration and invasion in human colorectal carcinoma HCT-116 cells through down-regulation of prostaglandin E2 receptor EP4.
Jeong JW; Park C; Cha HJ; Hong SH; Park SH; Kim GY; Kim WJ; Kim CH; Song KS; Choi YH
BMB Rep; 2018 Oct; 51(10):532-537. PubMed ID: 30269738
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
Oh JM; Kim SH; Lee YI; Seo M; Kim SY; Song YS; Kim WH; Juhnn YS
Carcinogenesis; 2009 Jan; 30(1):141-9. PubMed ID: 18849297
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
Fujino H; Salvi S; Regan JW
Mol Pharmacol; 2005 Jul; 68(1):251-9. PubMed ID: 15855407
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
Kanda N; Watanabe S
J Invest Dermatol; 2002 Nov; 119(5):1080-9. PubMed ID: 12445196
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of Epac1/Rap1/Akt and PKA in prostaglandin E(2) -induced proliferation of human umbilical cord blood derived mesenchymal stem cells: involvement of c-Myc and VEGF expression.
Jang MW; Yun SP; Park JH; Ryu JM; Lee JH; Han HJ
J Cell Physiol; 2012 Dec; 227(12):3756-67. PubMed ID: 22378492
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH
J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098
[TBL] [Abstract][Full Text] [Related]
18. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
[TBL] [Abstract][Full Text] [Related]
20. PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling.
Steinert D; Küper C; Bartels H; Beck FX; Neuhofer W
Am J Physiol Cell Physiol; 2009 Jan; 296(1):C75-87. PubMed ID: 19005164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
